Safety and Efficacy of KPI-121 in Subjects With Postsurgical Inflammation
Public ClinicalTrials.gov record NCT02163824. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase III, Double-Masked, Randomized, Controlled Trial of KPI-121 in Postsurgical Inflammation
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to determine the efficacy and safety of KPI-121 ophthalmic suspension compared to placebo in subjects who have undergone cataract surgery. The efficacy and safety of two different concentrations and two different dosing regimens of KPI-121 are also being assessed.
Study identification
- NCT ID
- NCT02163824
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 380 participants
Conditions and interventions
Interventions
- KPI-121 0.25% Drug
- KPI-121 1.0% Drug
- Vehicle of KPI-121 0.25% Drug
- Vehicle of KPI-121 1.0% Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2014 (Type not available)
- Primary completion
- Dec 2014 (Actual)
- Completion
- Dec 2014 (Actual)
- Last update posted
- Jan 29, 2021
2014
United States locations
- U.S. sites
- 23
- U.S. states
- 12
- U.S. cities
- 20
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Sall Research Medical Center | Artesia | California | 90701 | — |
| North Valley Eye Medical Group | Mission Hills | California | 91345 | — |
| Martel Eye Medical Group | Rancho Cordova | California | 95670 | — |
| Wolstan & Goldberg Eye Associates | Torrance | California | 90505 | — |
| Clayton Eye Center | Morrow | Georgia | 30260 | — |
| Price Vision Group | Indianapolis | Indiana | 46260 | — |
| John-Kenyon American Eye Institute | New Albany | Indiana | 47150 | — |
| Taustine Eye Center | Louisville | Kentucky | 40217 | — |
| Tauber Eye Center | Kansas City | Missouri | 64111 | — |
| Tekwani Vision Center | St Louis | Missouri | 63128 | — |
| Ophthalmology Associates | St Louis | Missouri | 63131 | — |
| Ophthalmology Consultants | St Louis | Missouri | 63131 | — |
| Las Vegas Physicians Research Group | Henderson | Nevada | 89052 | — |
| Raymond Fong, MDPC | New York | New York | 10013 | — |
| Rochester Ophthalmological Group, PC | Rochester | New York | 14618 | — |
| Cornerstone Eye Care | High Point | North Carolina | 27262 | — |
| Cincinnati Eye Institute | Cincinnati | Ohio | 45242 | — |
| The Eye Center of Columbus | Columbus | Ohio | 43215 | — |
| Westside Research, LLC | Spartanburg | South Carolina | 29306 | — |
| The Eye Clinic of Texas, Affiliate of Houston Eye Associates | League City | Texas | 77573 | — |
| R&R Eye Research, LLC | San Antonio | Texas | 78229 | — |
| Kozlovsky Delay & Winter Eye Consultants, LLC | San Antonio | Texas | 78230 | — |
| Virginia Eye Consultants | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02163824, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 29, 2021 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02163824 live on ClinicalTrials.gov.